The Wistar Institute   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Philadelphia PA United States (1892)

Organization Overview

First Clinical Trial
2007
NCT00100646
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

HIV-1 Immunopathogenesis Laboratory. The Wistar Institute | Luis Montaner | The Wistar Institute | Troy Messick